Product Information
RECTASMOOTHE 5% CREAM is a generic product labeled by Leading Pharma, LLC, priced at $0.4361 per GM under NDC 69315030130. Its NADAC has been published 147 times since Feb 8, 2023.
Strength
5 g/100g
Manufacturer
Leading Pharma, LLCNDC
69315030130
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
11/19/2025
Active Ingredients
LIDOCAINEApproval Type
OTC Monograph
FDA Application
part346On Market Since
4/1/2011
Pharmacological Classes
Price Statistics
The NADAC for RECTASMOOTHE 5% CREAM has been published 147 times since Feb 8, 2023, and over the history we have for it it has risen 22.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4361 per GM |
|---|---|
| All-time high | $0.4883 (Jul 16, 2025) |
| All-time low | $0.2633 (Jul 17, 2024) |
| 52-week high | $0.4655 |
| 52-week low | $0.4361 |
| Median price | $0.4250 |
| Average price | $0.4126 |
| Largest weekly change | +47.8% (May 17, 2023) |
| Weeks tracked | 147 |
| Tracking since | Feb 8, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-2.0%
3Y
+38.6%
5Y
N/A
All
+22.1%
Last surveyed Nov 26, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lidocaine 5% market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RECTASMOOTHE 5% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for RECTASMOOTHE 5% CREAM, manufactured by Leading Pharma, LLC, is $0.4361 per GM (NDC 69315030130), effective Nov 26, 2025.
How has the price of RECTASMOOTHE 5% CREAM changed over time?
Over the history we have for it, the NADAC for RECTASMOOTHE 5% CREAM has risen 22.1%. It has been tracked across 147 weekly CMS publications since Feb 8, 2023.
What are the highest and lowest recorded NADAC prices for RECTASMOOTHE 5% CREAM?
Since Feb 8, 2023, the NADAC for RECTASMOOTHE 5% CREAM has ranged from a low of $0.2633 (Jul 17, 2024) to a high of $0.4883 (Jul 16, 2025), with a median of $0.4250 per GM.
Are there cheaper alternatives to RECTASMOOTHE 5% CREAM?
No other NADAC-published product currently shares the active ingredient and strength of RECTASMOOTHE 5% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures RECTASMOOTHE 5% CREAM?
RECTASMOOTHE 5% CREAM (NDC 69315030130) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.